What is the Prognosis for Patients with HER2-Positive Cancers?
The prognosis for patients with HER2-positive cancers has improved significantly with the advent of targeted therapies. However, HER2-positive cancers are generally more aggressive and have a higher risk of recurrence compared to HER2-negative cancers. The use of HER2-targeted therapies, often in combination with chemotherapy, has led to better response rates and prolonged survival in patients with HER2-positive cancers.
